Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
|
February 7, 2018
Necrotizing fungal gingivitis in a patient with Acute Myelogenous Leukemia: visible yet obscure
Prajwal Boddu, Pei-Ling Chen, Priyadharsini Nagarajan, et al.
Annals of Hematology
|
November 17, 2017
Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms
Prajwal Boddu, Lucia Masarova, Srdan Verstovsek, et al.
Hematology/Oncology and Stem Cell Therapy
|
August 24, 2017
Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia-A case report
Prajwal Boddu, Ellen Schlette, Beenu Thakral, et al.
Case Reports in Hematology
|
October 28, 2017
An Unsuspected Finding of t(9;22): A Rare Case of Philadelphia Chromosome-Positive B-Lymphoblastic Lymphoma
Prajwal Boddu, C Cameron Yin, Rashmi Kanagal-Shamanna, et al.
Blood Advances
|
January 4, 2018
Co-occurrence of <i>FLT3</i>-TKD and <i>NPM1</i> mutations defines a highly favorable prognostic AML group
Prajwal Boddu, Hagop Kantarjian, Gautam Borthakur, et al.
Journal of Clinical Pathology
|
November 24, 2018
Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluation
Prajwal Boddu, Beenu Thakral, Ahmed Alhuraiji, et al.
Leukemia & Lymphoma
|
May 25, 2019
Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy
Prajwal Boddu, Preetesh Jain, Gautam Borthakur, et al.
American Journal of Hematology
|
October 14, 2017
Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors
Ahmad Alhuraiji, Hagop Kantarjian, Prajwal Boddu, et al.
Leukemia & Lymphoma
|
October 4, 2017
Life after ponatinib failure: outcomes of chronic and accelerated phase CML patients who discontinued ponatinib in the salvage setting
Prajwal Boddu, Abdul Rashid Shah, Gautam Borthakur, et al.
Cell Reports
|
January 2, 2024
The FANCI/FANCD2 complex links DNA damage response to R-loop regulation through SRSF1-mediated mRNA export
Anne Olazabal-Herrero, Boxue He, Youngho Kwon, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
|
February 7, 2018
Necrotizing fungal gingivitis in a patient with Acute Myelogenous Leukemia: visible yet obscure
Prajwal Boddu, Pei-Ling Chen, Priyadharsini Nagarajan, et al.
Annals of Hematology
|
November 17, 2017
Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms
Prajwal Boddu, Lucia Masarova, Srdan Verstovsek, et al.
Hematology/Oncology and Stem Cell Therapy
|
August 24, 2017
Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia-A case report
Prajwal Boddu, Ellen Schlette, Beenu Thakral, et al.
Case Reports in Hematology
|
October 28, 2017
An Unsuspected Finding of t(9;22): A Rare Case of Philadelphia Chromosome-Positive B-Lymphoblastic Lymphoma
Prajwal Boddu, C Cameron Yin, Rashmi Kanagal-Shamanna, et al.
Blood Advances
|
January 4, 2018
Co-occurrence of <i>FLT3</i>-TKD and <i>NPM1</i> mutations defines a highly favorable prognostic AML group
Prajwal Boddu, Hagop Kantarjian, Gautam Borthakur, et al.
Journal of Clinical Pathology
|
November 24, 2018
Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluation
Prajwal Boddu, Beenu Thakral, Ahmed Alhuraiji, et al.
Leukemia & Lymphoma
|
May 25, 2019
Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy
Prajwal Boddu, Preetesh Jain, Gautam Borthakur, et al.
American Journal of Hematology
|
October 14, 2017
Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors
Ahmad Alhuraiji, Hagop Kantarjian, Prajwal Boddu, et al.
Leukemia & Lymphoma
|
October 4, 2017
Life after ponatinib failure: outcomes of chronic and accelerated phase CML patients who discontinued ponatinib in the salvage setting
Prajwal Boddu, Abdul Rashid Shah, Gautam Borthakur, et al.
Cell Reports
|
January 2, 2024
The FANCI/FANCD2 complex links DNA damage response to R-loop regulation through SRSF1-mediated mRNA export
Anne Olazabal-Herrero, Boxue He, Youngho Kwon, et al.
Page
of 4